Krüger et al (2003) showed Mcm2 expression to be the only parameter predicting progression in 52 pT1 tumours. Korkolopoulou et al (2005) found Mcm2 and Mcm5 to indicate adverse outcome in 65 muscle invasive bladder cancers. Here, MCM2 is linked to neoplasm.